Saroja Pharma Industries India Ltd.
•₹ 34.44.88%
2026-08-21
PROS
- Strong cash generation - operating cash flow backs reported profits (CFO/PAT 1.47x)
- Working capital cycle has improved - days down from 75 to 32
- Company converts assets efficiently - asset turnover of 1.6x
CONS
- Receivables are growing faster than sales - a possible quality concern
- Total debt has risen sharply - up 64.9% year on year
- Free cash flow has been persistently negative
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
EDIT COLUMNS| S.No. | Name | CMP Rs. | P/E | Mar Cap Rs.Cr. | Div Yld % | NP Qtr Rs.Cr. | Qtr Profit Var % | Sales Qtr Rs.Cr. | Qtr Sales Var % | ROCE % | OPM % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | SUNPHARMA | 1898.00 | 37.65 | 455393.78 | 0.84 | 2901.23 | 26.53 | 15299.88 | 10.98 | 19.11 | 28.81 |
| 2. | DIVISLAB | 8525.00 | 77.37 | 226311.96 | 0.35 | 902.00 | 65.50 | 3080.00 | 27.80 | 21.51 | 40.75 |
| 3. | TORNTPHARM | 5013.00 | 87.43 | 190678.41 | 0.76 | 566.00 | 3.28 | 4921.00 | 57.32 | 19.27 | 33.81 |
| 4. | CIPLA | 1416.00 | 33.94 | 114392.01 | 0.92 | 785.55 | -39.18 | 7119.28 | 4.13 | 16.00 | 16.73 |
| 5. | ZYDUSLIFE | 1105.00 | 24.42 | 110224.17 | 0.09 | 990.20 | -34.90 | 8017.00 | 23.97 | 21.39 | 24.54 |
| 6. | LUPIN | 2220.00 | 18.36 | 101506.15 | 0.81 | 1416.98 | 16.01 | 8276.89 | 34.28 | 28.86 | 29.59 |
| 7. | MANKIND | 2391.00 | 48.34 | 98747.34 | 0.04 | 574.09 | 29.12 | 4030.59 | 12.89 | 13.24 | 26.30 |
| 8. | DRREDDY | 1171.00 | 30.33 | 97740.54 | 0.68 | 435.60 | -69.10 | 8099.80 | -5.21 | 13.75 | 10.63 |
| 9. | LAURUSLABS | 1807.00 | 89.30 | 97634.42 | 0.11 | 362.07 | 123.94 | 2026.31 | 29.10 | 18.20 | 31.50 |
| 10. | AUROPHARMA | 1615.15 | 25.03 | 92932.16 | 0.25 | 1032.03 | 25.22 | 9150.35 | 17.44 | 12.76 | 20.54 |
| 11. | BIOCON | 414.30 | 136.32 | 67518.23 | 0.12 | 136.80 | 53.36 | 4336.00 | 10.89 | 3.26 | 19.54 |
| 12. | SAROJA | 32.80 | 0.00 | 13.19 | 0.00 | — | — | — | — | 12.56 | — |
Detailed Comparison with:
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
No quarterly results found
We don't have this information yet. Please check back later.
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| 37 | 56 | 50 | 41 | 54 | |
| 35 | 54 | 47 | 38 | 51 | |
| Operating Profit | 1 | 2 | 3 | 3 | 3 |
| OPM % | 4 | 4 | 6 | 7 | 6 |
| Other Income | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 1 | 1 | 1 | 1 |
| Depreciation | 0 | 0 | 0 | 0 | 0 |
| 1 | 2 | 1 | 1 | 1 | |
| Tax % | 29 | 28 | 29 | 27 | 29 |
| Net Profit | 1 | 1 | 1 | 1 | 1 |
| EPS | 3 | 4 | 4 | 2 | 3 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 56 | 4 | 4 | 2 | 3 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 56 | 4 | 4 | 2 | 3 |
Mar 2021
- 37
- 35
- Operating Profit
- 1
- OPM %
- 4
- Other Income
- 0
- Interest
- 0
- Depreciation
- 0
- 1
- Tax %
- 29
- Net Profit
- 1
- EPS
- 3
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 56
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 56
Mar 2022
- 56
- 54
- Operating Profit
- 2
- OPM %
- 4
- Other Income
- 0
- Interest
- 1
- Depreciation
- 0
- 2
- Tax %
- 28
- Net Profit
- 1
- EPS
- 4
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 4
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 4
Mar 2023
- 50
- 47
- Operating Profit
- 3
- OPM %
- 6
- Other Income
- 0
- Interest
- 1
- Depreciation
- 0
- 1
- Tax %
- 29
- Net Profit
- 1
- EPS
- 4
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 4
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 4
Mar 2024
- 41
- 38
- Operating Profit
- 3
- OPM %
- 7
- Other Income
- 0
- Interest
- 1
- Depreciation
- 0
- 1
- Tax %
- 27
- Net Profit
- 1
- EPS
- 2
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 2
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 2
Mar 2025
- 54
- 51
- Operating Profit
- 3
- OPM %
- 6
- Other Income
- 0
- Interest
- 1
- Depreciation
- 0
- 1
- Tax %
- 29
- Net Profit
- 1
- EPS
- 3
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 3
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 3
COMPOUNDED SALES GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- -1%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- -3%
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
- 1 Year:
- -16%
RETURN ON EQUITY
- 10 Years:
- —
- 5 Years:
- 33%
- 3 Years:
- 13%
- Last Year:
- 7%
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| LIABILITIES | - | - | - | - | - |
| Equity Capital | 0 | 0 | 3 | 4 | 4 |
| 1 | 4 | 2 | 11 | 12 | |
| 2 | 4 | 7 | 3 | 8 | |
| Trade Payables | 4 | 5 | 6 | 6 | 14 |
| 2 | 2 | 3 | 3 | 2 | |
| Total Liabilities | 8 | 16 | 21 | 27 | 40 |
| ASSETS | - | - | - | - | - |
| 0 | 0 | 2 | 3 | 3 | |
| Capital Work in Progress | 0 | 0 | 2 | 6 | 9 |
| 1 | 0 | 4 | 0 | 0 | |
| 0 | 0 | 0 | 16 | 27 | |
| 7 | 14 | 13 | 1 | 1 | |
| Total Assets | 8 | 16 | 21 | 27 | 40 |
| Total Debt | 3 | 6 | 10 | 6 | 9 |
| Net Working Capital | 2 | 5 | 3 | 8 | 5 |
| Contingent Liabilities | 0 | 0 | 0 | 0 | 0 |
| Book Value per Share | 935.90 | 178.30 | 17.33 | 36.42 | 38.99 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Total Debt | 3 | 6 | 10 | 6 | 9 |
| Net Working Capital | 2 | 5 | 3 | 8 | 5 |
| Contingent Liabilities | 0 | 0 | 0 | 0 | 0 |
| Book Value per Share | 935.90 | 178.30 | 17.33 | 36.42 | 38.99 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
Mar 2021
- Equity Capital
- 0
- 1
- 2
- Trade Payables
- 4
- 2
- Total Liabilities
- 8
- 0
- Capital Work in Progress
- 0
- 1
- 0
- 7
- Total Assets
- 8
- Total Debt
- 3
- Net Working Capital
- 2
- Contingent Liabilities
- 0
- Book Value per Share
- 935.90
- Face Value
- 10.00
- Total Debt
- 3
- Net Working Capital
- 2
- Contingent Liabilities
- 0
- Book Value per Share
- 935.90
- Face Value
- 10.00
Mar 2022
- Equity Capital
- 0
- 4
- 4
- Trade Payables
- 5
- 2
- Total Liabilities
- 16
- 0
- Capital Work in Progress
- 0
- 0
- 0
- 14
- Total Assets
- 16
- Total Debt
- 6
- Net Working Capital
- 5
- Contingent Liabilities
- 0
- Book Value per Share
- 178.30
- Face Value
- 10.00
- Total Debt
- 6
- Net Working Capital
- 5
- Contingent Liabilities
- 0
- Book Value per Share
- 178.30
- Face Value
- 10.00
Mar 2023
- Equity Capital
- 3
- 2
- 7
- Trade Payables
- 6
- 3
- Total Liabilities
- 21
- 2
- Capital Work in Progress
- 2
- 4
- 0
- 13
- Total Assets
- 21
- Total Debt
- 10
- Net Working Capital
- 3
- Contingent Liabilities
- 0
- Book Value per Share
- 17.33
- Face Value
- 10.00
- Total Debt
- 10
- Net Working Capital
- 3
- Contingent Liabilities
- 0
- Book Value per Share
- 17.33
- Face Value
- 10.00
Mar 2024
- Equity Capital
- 4
- 11
- 3
- Trade Payables
- 6
- 3
- Total Liabilities
- 27
- 3
- Capital Work in Progress
- 6
- 0
- 16
- 1
- Total Assets
- 27
- Total Debt
- 6
- Net Working Capital
- 8
- Contingent Liabilities
- 0
- Book Value per Share
- 36.42
- Face Value
- 10.00
- Total Debt
- 6
- Net Working Capital
- 8
- Contingent Liabilities
- 0
- Book Value per Share
- 36.42
- Face Value
- 10.00
Mar 2025
- Equity Capital
- 4
- 12
- 8
- Trade Payables
- 14
- 2
- Total Liabilities
- 40
- 3
- Capital Work in Progress
- 9
- 0
- 27
- 1
- Total Assets
- 40
- Total Debt
- 9
- Net Working Capital
- 5
- Contingent Liabilities
- 0
- Book Value per Share
- 38.99
- Face Value
- 10.00
- Total Debt
- 9
- Net Working Capital
- 5
- Contingent Liabilities
- 0
- Book Value per Share
- 38.99
- Face Value
- 10.00
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| -1 | -4 | 2 | 1 | 1 | |
| Cash from Investing | -0 | -0 | -5 | -5 | -3 |
| Cash from Financing | 1 | 4 | 3 | 4 | 2 |
| -0 | 0 | 0 | -0 | 0 | |
| Free Cash Flow | -1 | -4 | -2 | -4 | -1 |
| OCF / Net Profit | -1.43 | -3.22 | 2.07 | 1.17 | 1.11 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 0 |
| OCF / Net Profit | -1.43 | -3.22 | 2.07 | 1.17 | 1.11 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 0 |
Mar 2021
- -1
- Cash from Investing
- -0
- Cash from Financing
- 1
- -0
- Free Cash Flow
- -1
- OCF / Net Profit
- -1.43
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -1.43
- Cumulative 5-Year FCF
- 0
Mar 2022
- -4
- Cash from Investing
- -0
- Cash from Financing
- 4
- 0
- Free Cash Flow
- -4
- OCF / Net Profit
- -3.22
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -3.22
- Cumulative 5-Year FCF
- 0
Mar 2023
- 2
- Cash from Investing
- -5
- Cash from Financing
- 3
- 0
- Free Cash Flow
- -2
- OCF / Net Profit
- 2.07
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 2.07
- Cumulative 5-Year FCF
- 0
Mar 2024
- 1
- Cash from Investing
- -5
- Cash from Financing
- 4
- -0
- Free Cash Flow
- -4
- OCF / Net Profit
- 1.17
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 1.17
- Cumulative 5-Year FCF
- 0
Mar 2025
- 1
- Cash from Investing
- -3
- Cash from Financing
- 2
- 0
- Free Cash Flow
- -1
- OCF / Net Profit
- 1.11
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 1.11
- Cumulative 5-Year FCF
- 0
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| PER SHARE | - | - | - | - | - |
| EPS (₹) | 731.30 | 50.49 | 3.61 | 2.18 | 2.57 |
| Book Value (₹) | 935.90 | 178.30 | 17.33 | 36.42 | 38.99 |
| Dividend per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash EPS (₹) | 57.98 | 4.04 | 3.84 | 2.42 | 2.86 |
| PROFITABILITY | - | - | - | - | - |
| Operating Margin % | 3.79% | 4.36% | 5.73% | 6.29% | 5.19% |
| Net Margin % | 1.99% | 2.05% | 2.11% | 2.16% | 1.92% |
| ROE % | 78.14% | 45.95% | 23.28% | 8.90% | 6.82% |
| ROCE % | 34.59% | 33.73% | 22.10% | 14.91% | 12.56% |
| 8.89% | 9.61% | 5.76% | 3.67% | 3.13% | |
| EFFICIENCY | - | - | - | - | - |
| Debtor Days | 72 | 70 | 91 | 123 | 145 |
| Inventory Days | 7 | 4 | 16 | 19 | 2 |
| Payable Days | 47 | 36 | 46 | 62 | 75 |
| 31 | 38 | 61 | 80 | 73 | |
| FINANCIAL HEALTH | - | - | - | - | - |
| Debt to Equity (x) | 3.22x | 1.52x | 2.00x | 0.39x | 0.60x |
| Interest Coverage (x) | 4.12x | 2.97x | 2.13x | 1.83x | 2.03x |
| 1.38x | 1.54x | 1.20x | 1.89x | 1.21x | |
| GROWTH | - | - | - | - | - |
| Revenue Growth % | 0.00% | 51.75% | -9.78% | -18.97% | 32.11% |
| Operating Profit Growth % | 0.00% | 74.62% | 18.58% | -4.39% | 8.05% |
| Net Profit Growth % | 0.00% | 55.90% | -6.97% | -17.19% | 17.75% |
| 0.00% | 0.00% | 0.00% | -39.53% | 17.75% | |
| VALUATION | - | - | - | - | - |
| P/E (x) | 0.00x | 0.00x | 0.00x | 16.07x | 14.68x |
| P/B (x) | 0.00x | 0.00x | 0.00x | 0.96x | 0.97x |
| Dividend Yield % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 0.00x | 0.00x | 0.00x | 7.10x | 8.17x |
Mar 2021
- EPS (₹)
- 731.30
- Book Value (₹)
- 935.90
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 57.98
- Operating Margin %
- 3.79%
- Net Margin %
- 1.99%
- ROE %
- 78.14%
- ROCE %
- 34.59%
- 8.89%
- Debtor Days
- 72
- Inventory Days
- 7
- Payable Days
- 47
- 31
- Debt to Equity (x)
- 3.22x
- Interest Coverage (x)
- 4.12x
- 1.38x
- Revenue Growth %
- 0.00%
- Operating Profit Growth %
- 0.00%
- Net Profit Growth %
- 0.00%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2022
- EPS (₹)
- 50.49
- Book Value (₹)
- 178.30
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 4.04
- Operating Margin %
- 4.36%
- Net Margin %
- 2.05%
- ROE %
- 45.95%
- ROCE %
- 33.73%
- 9.61%
- Debtor Days
- 70
- Inventory Days
- 4
- Payable Days
- 36
- 38
- Debt to Equity (x)
- 1.52x
- Interest Coverage (x)
- 2.97x
- 1.54x
- Revenue Growth %
- 51.75%
- Operating Profit Growth %
- 74.62%
- Net Profit Growth %
- 55.90%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2023
- EPS (₹)
- 3.61
- Book Value (₹)
- 17.33
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 3.84
- Operating Margin %
- 5.73%
- Net Margin %
- 2.11%
- ROE %
- 23.28%
- ROCE %
- 22.10%
- 5.76%
- Debtor Days
- 91
- Inventory Days
- 16
- Payable Days
- 46
- 61
- Debt to Equity (x)
- 2.00x
- Interest Coverage (x)
- 2.13x
- 1.20x
- Revenue Growth %
- -9.78%
- Operating Profit Growth %
- 18.58%
- Net Profit Growth %
- -6.97%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2024
- EPS (₹)
- 2.18
- Book Value (₹)
- 36.42
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 2.42
- Operating Margin %
- 6.29%
- Net Margin %
- 2.16%
- ROE %
- 8.90%
- ROCE %
- 14.91%
- 3.67%
- Debtor Days
- 123
- Inventory Days
- 19
- Payable Days
- 62
- 80
- Debt to Equity (x)
- 0.39x
- Interest Coverage (x)
- 1.83x
- 1.89x
- Revenue Growth %
- -18.97%
- Operating Profit Growth %
- -4.39%
- Net Profit Growth %
- -17.19%
- -39.53%
- P/E (x)
- 16.07x
- P/B (x)
- 0.96x
- Dividend Yield %
- 0.00%
- 7.10x
Mar 2025
- EPS (₹)
- 2.57
- Book Value (₹)
- 38.99
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 2.86
- Operating Margin %
- 5.19%
- Net Margin %
- 1.92%
- ROE %
- 6.82%
- ROCE %
- 12.56%
- 3.13%
- Debtor Days
- 145
- Inventory Days
- 2
- Payable Days
- 75
- 73
- Debt to Equity (x)
- 0.60x
- Interest Coverage (x)
- 2.03x
- 1.21x
- Revenue Growth %
- 32.11%
- Operating Profit Growth %
- 8.05%
- Net Profit Growth %
- 17.75%
- 17.75%
- P/E (x)
- 14.68x
- P/B (x)
- 0.97x
- Dividend Yield %
- 0.00%
- 8.17x
Documents
Announcements
Nothing filed yet.
Annual Reports
Credit Ratings
Nothing filed yet.
Concalls
Nothing filed yet.